April 2022 FAQs
- What is the place in therapy for empagliflozin for heart failure?
- What drug therapy is recommended for management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy?
- What is the optimal sequencing for first-line treatment of BRAF-mutated metastatic melanoma?